Innovative Therapies

Globally, diabetes affects over 463 million adults, with type 2 diabetes accounting for about 90% of cases. New therapies like SGLT2 inhibitors and GLP-1 receptor agonists have shown promise in managing blood glucose and weight. For example, SGLT2 inhibitors have been associated with a 30% reduction in hospitalization for heart failure. Continued research into beta-cell regeneration and immunotherapy could offer hope for future breakthroughs.

    Related Conference of Innovative Therapies

    February 20-21, 2025

    8th International Conference on Food Safety and Health

    Amsterdam, Netherlands
    February 24-25, 2025

    31st International Conference on Clinical Nutrition

    London, UK
    March 10-11, 2025

    7th World Summit on Health Nutrition

    Paris, France
    June 24-25, 2025

    24th International Congress on Nutrition and Health

    Amsterdam, Netherlands
    July 07-08, 2025

    32nd European Nutrition and Dietetics Conference

    Zurich, Switzerland
    September 08-09, 2025

    24th World Congress on Nutrition and Food Chemistry

    Frankfurt, Germany
    September 15-16, 2025

    29th World Congress on Nutrition and Food Sciences

    Aix-en-Provence, France
    December 08-09, 2025

    8th World Congress on Food and Nutrition

    Rome, Italy

    Innovative Therapies Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in